Form 4: HealthStream Director Bolsters Stake with Stock Compensation and RSU Grant

HealthStream Inc. Director Frank Gordon increased his beneficial ownership by acquiring common stock in lieu of cash compensation and receiving a grant of Restricted Share Units.

Summary

• HealthStream Inc. Director Frank Gordon acquired 1,174 shares of common stock on May 29, 2025, at a price of $27.89 per share.
• These shares were received as an election to take stock in lieu of cash compensation for his service on the Company's Board of Directors.
• Mr. Gordon's direct beneficial ownership of common stock now totals 208,790 shares following this transaction.
• He also maintains indirect beneficial ownership of 100,418 shares held by Crofton Capital, 11,386 shares held by The Joel Company, 2,500 shares in a custodial account for Gavin B. Gordon, 2,500 shares in a custodial account for Cameron L. Gordon, 2,000 shares in a custodial account for Taylor K. Gordon, and 2,000 shares held by the Frank E. Gordon 2003 Family Trust.
• Additionally, Mr. Gordon was granted 3,048 Restricted Share Units (RSUs) on May 29, 2025, with a conversion price of $0, representing the contingent right to receive one share of common stock per unit.
• These RSUs are subject to a three-year vesting schedule, with annual vesting in three equal installments commencing on May 29, 2026, contingent upon his continued service to the company.

Sentiment

Score: 7

Explanation: The filing indicates a director increasing their stake through compensation, which is generally a positive signal of alignment and commitment, though not a direct open market purchase.

Positives

• Director Frank Gordon elected to receive common stock instead of cash for his board service, which directly aligns his financial interests with those of the company's shareholders.
• The grant of 3,048 Restricted Share Units (RSUs) further incentivizes the director's long-term commitment and performance, as vesting is contingent on continued service over three years.
• The overall increase in the director's beneficial ownership demonstrates continued confidence and commitment to HealthStream Inc.

Future Outlook

The vesting schedule for the Restricted Share Units (RSUs) indicates a future alignment of the director's compensation with the company's long-term performance, with vesting occurring annually over three years starting May 29, 2026, contingent on continued service.

Industry Context

This Form 4 filing reflects standard compensation practices for directors in publicly traded companies, often involving a mix of cash and equity to align interests with shareholders. In the healthcare technology sector, retaining experienced board members is crucial for strategic guidance and market navigation.

Comparison to Industry Standards

• The practice of compensating directors with equity, such as common stock in lieu of cash and Restricted Share Units (RSUs), is a common corporate governance practice across industries, including healthcare technology.
• This method is widely adopted by companies like Cerner (now Oracle Health), Allscripts (now Veradigm), and Veeva Systems, as it ties director incentives directly to the company's stock performance, fostering long-term value creation.
• The three-year vesting schedule for RSUs is also a standard approach to ensure continued service and commitment from board members, comparable to similar arrangements seen in other tech and healthcare firms.

Corporate Governance

Stakeholder Impact

• **Shareholders:** Increased alignment of a director's interests with shareholders due to equity-based compensation, potentially fostering long-term value creation.
• **Employees:** No direct impact on general employees, but reflects standard executive/director compensation practices.

Next Steps

• Continued service of Frank Gordon on the HealthStream Inc. Board of Directors to ensure vesting of Restricted Share Units.
• Annual vesting of Restricted Share Units beginning May 29, 2026, over a three-year period.

Key Dates

Recommendation

Keywords

HealthStream, HSTM, SEC Form 4, Insider Transaction, Beneficial Ownership, Director Compensation, Restricted Share Units, Stock Acquisition, Corporate Governance, Healthcare Technology